Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Carpentier

Showing results (41-50 of 84) with videos related to

Pageof 9
Sort By:
Cytometry|January 1, 1990
Alterations of growth fraction and DNA content in K562 cells by differentiating agentsM C Gorisse, Y Carpentier, P Joly, et al.
Social Science & Medicine (1982)|March 20, 2012
Longitudinal effects of health-harming and health-protective behaviors within adolescent romantic dyadsMatthew C Aalsma, Melissa Y Carpentier, Faouzi Azzouz, et al.
European Urology|August 23, 2003
Erectile dysfunction is associated with a high prevalence of hyperlipidemia and coronary heart disease riskTh Roumeguère, E Wespes, Y Carpentier, et al.
Comptes Rendus Des Seances De L'Academie Des Sciences. Serie III, Sciences De La Vie|February 16, 1981
[Effect of methotrexate on oxygen consumption of L1210 cells and their isolated mitochondria]J Kouamouo, C Trentesaux, B Desoize, et al.
Arzneimittel-Forschung|January 1, 1984
Effects of a new antitumor compound, mopidamol, on thymidine and 2-deoxyglucose transport in leukaemic L 1210 cellsC Trentesaux, P Jeannesson, Y Carpentier, et al.
Acta Gastro-Enterologica Belgica|May 1, 1985
[Trace elements and total parenteral nutrition]A Bailly, Y Carpentier, N Thoonart, et al.
Anticancer Research|November 1, 1993
Chronology of combined chemotherapy (5FU) and radiotherapy. II. In vivo studyL Demange, Y Carpentier, M Loirette, et al.
Leukemia Research|January 1, 1989
Quantitative morphological aspects of granulocytic differentiation induced in HL-60 cells by dimethylsulfoxide and retinoic acidJ Dufer, D Biakou, P Joly, et al.
Cancer Treatment Reports|December 1, 1982
Phase I study of SOAzS Nasca, D Jezekova, P Coninx, et al.
Muscle & Nerve|August 13, 2008
Disease-specific measure of quality of life for myasthenia gravisLarry L Mullins, Melissa Y Carpentier, Robert H Paul, et al.
Pageof 9

Showing results (41-50 of 84) with videos related to

Sort By:
Pageof 9
Cytometry|January 1, 1990
Alterations of growth fraction and DNA content in K562 cells by differentiating agentsM C Gorisse, Y Carpentier, P Joly, et al.
Social Science & Medicine (1982)|March 20, 2012
Longitudinal effects of health-harming and health-protective behaviors within adolescent romantic dyadsMatthew C Aalsma, Melissa Y Carpentier, Faouzi Azzouz, et al.
European Urology|August 23, 2003
Erectile dysfunction is associated with a high prevalence of hyperlipidemia and coronary heart disease riskTh Roumeguère, E Wespes, Y Carpentier, et al.
Comptes Rendus Des Seances De L'Academie Des Sciences. Serie III, Sciences De La Vie|February 16, 1981
[Effect of methotrexate on oxygen consumption of L1210 cells and their isolated mitochondria]J Kouamouo, C Trentesaux, B Desoize, et al.
Arzneimittel-Forschung|January 1, 1984
Effects of a new antitumor compound, mopidamol, on thymidine and 2-deoxyglucose transport in leukaemic L 1210 cellsC Trentesaux, P Jeannesson, Y Carpentier, et al.
Acta Gastro-Enterologica Belgica|May 1, 1985
[Trace elements and total parenteral nutrition]A Bailly, Y Carpentier, N Thoonart, et al.
Anticancer Research|November 1, 1993
Chronology of combined chemotherapy (5FU) and radiotherapy. II. In vivo studyL Demange, Y Carpentier, M Loirette, et al.
Leukemia Research|January 1, 1989
Quantitative morphological aspects of granulocytic differentiation induced in HL-60 cells by dimethylsulfoxide and retinoic acidJ Dufer, D Biakou, P Joly, et al.
Cancer Treatment Reports|December 1, 1982
Phase I study of SOAzS Nasca, D Jezekova, P Coninx, et al.
Muscle & Nerve|August 13, 2008
Disease-specific measure of quality of life for myasthenia gravisLarry L Mullins, Melissa Y Carpentier, Robert H Paul, et al.
Pageof 9